Clinical trials in Ranica – page 165

Innovative research focusing on membranoproliferative glomerulonephritis and related conditions, evaluating novel therapeutic approaches including iptacopan and pegcetacoplan for treating various forms of kidney inflammation.

• IC-MPGN Treatment Evaluation
• C3 Glomerulopathy Research
• Post-Transplant Recurrence Studies

Multiple trials aim to reduce proteinuria and improve long-term kidney function outcomes.

Comprehensive studies examining treatments for IgA Nephropathy and membranous nephropathy, including investigations of sparsentan and specialized antibody therapies for patients resistant to conventional treatments.

• Primary Membranous Nephropathy
• IgA Nephropathy Interventions
• Antibody-Based Treatments

Focus on proteinuria reduction and preservation of renal function in various nephropathy types.

Advanced research into non-diabetic chronic kidney disease, exploring new therapeutic options including finerenone and investigating treatments for complications like hyperkalemia.

• Disease Progression Prevention
• Hyperkalemia Management
• Long-term Kidney Function

Studies aim to delay disease progression and improve standard of care outcomes.